Topic

Pennsylvania

A collection of 524 issues

Getting Cimzia (Certolizumab Pegol) Approved by UnitedHealthcare in Pennsylvania: A Real Patient's Journey from Denial to Coverage

Answer Box: Fast Track to Cimzia Coverage UnitedHealthcare requires prior authorization for Cimzia in Pennsylvania. Most approvals succeed with: (1) Complete TB/hepatitis screening, (2) documented failure of conventional therapies, and (3) specialist consultation. If denied, Pennsylvania's new external review program overturns ~50% of cases within 45 days.
5 min read

How to Get Enhertu Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization Guide with Appeals Process

Answer Box: Getting Enhertu Covered by Aetna CVS Health in Pennsylvania Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Aetna CVS Health for all FDA-approved cancer indications. Your oncologist must submit documentation proving HER2-positive, HER2-low, or HER2-mutant status plus evidence of prior therapy failures. The fastest path: gather HER2 testing results
6 min read

How to Get Bavencio (Avelumab) Covered by Aetna CVS Health in Pennsylvania: Prior Authorization Guide, ICD-10 Codes, and Appeals Process

Answer Box: Getting Bavencio Covered by Aetna CVS Health in Pennsylvania Aetna CVS Health requires prior authorization for Bavencio (avelumab) in Pennsylvania. The fastest path to approval: 1) Verify your oncologist submits the PA request with confirmed ICD-10 diagnosis codes (C4A for Merkel cell carcinoma, C67 for urothelial carcinoma) and
5 min read

How to Get Kymriah (tisagenlecleucel) Covered by Aetna CVS Health in Pennsylvania: Complete Guide to Approval, Appeals, and Renewal

Answer Box: Getting Kymriah Covered by Aetna CVS Health in Pennsylvania Kymriah (tisagenlecleucel) requires prior authorization from Aetna CVS Health. Start by having your oncologist submit a Letter of Medical Necessity documenting your CD19+ B-cell ALL or DLBCL, prior therapy failures, and treatment at a FACT-accredited center. If denied, you
5 min read

How to Get Galafold (Migalastat) Covered by UnitedHealthcare in Pennsylvania: Complete Guide with Forms, Appeals, and State Resources

Answer Box: Getting Galafold Covered by UnitedHealthcare in Pennsylvania Quick Path to Approval: UnitedHealthcare requires prior authorization for Galafold (migalastat) through OptumRx using Program 2024 P 1258-7. You need confirmed amenable GLA variant testing and cannot be on concurrent enzyme replacement therapy. Submit via the UnitedHealthcare Provider Portal or fax
6 min read

Denied for Idelvion by Blue Cross Blue Shield in Pennsylvania? Complete Appeal Guide (Forms, Timelines & Scripts)

Answer Box: Getting Idelvion Covered by Blue Cross Blue Shield in Pennsylvania Blue Cross Blue Shield Pennsylvania requires prior authorization for Idelvion (albutrepenonacog alfa), but approval is achievable with proper documentation. Most denials stem from missing factor IX deficiency confirmation, inhibitor status, or inadequate step therapy documentation. If denied, you
7 min read

How to Get Translarna (Ataluren) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Translarna (Ataluren) Covered by Aetna CVS Health in Pennsylvania Current Status: Translarna (ataluren) lacks FDA approval as of late 2024, so Aetna CVS Health typically denies coverage for nonsense mutation Duchenne muscular dystrophy (DMD) in Pennsylvania. However, you can still pursue coverage through prior authorization with medical
6 min read

How to Renew Entresto (Sacubitril/Valsartan) Coverage with Cigna in Pennsylvania: Timing, Documents, and Appeals

Answer Box Renewing Entresto (sacubitril/valsartan) with Cigna in Pennsylvania requires proactive planning 30-60 days before your current authorization expires. Submit renewal requests through CoverMyMeds or call 1-800-882-4462. Include updated lab results (renal function, potassium), current dosing (target 97/103 mg BID), and clinical response documentation. If coverage lapses, Pennsylvania&
6 min read